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From the Departments ofMedicine and of Pathology, University of Leicester, Leicester Royal Infirmary, Leicester SUMMARY A case is reported of delayed broncho-oesophageal fistula presenting several weeks after fibreoptic injection sclerotherapy for oesophageal varices in a patient with chronic active hepatitis who eventually died from bronchopneumonia. Such serious complications of injection sclerotherapy should be kept in mind with the increasing popularity of this method of early treatment of bleeding oesophageal varices.
In recent years there has been increasing interest in the use of endoscopic injection sclerotherapy for the treatment of bleeding oesophageal varices.1-10 Rigid1-9 10 and fibreoptic3 7 § 10 endoscopes have been used in this technique and a number of modifications have been introduced to enable compression of varices to be achieved during the injection procedure.7 8 1012 The complications arising from sclerotherapy range from substernal pain, 2 7-9 oesophageal bleeding,4 5 8 9 ulceration and sloughing of the oesophageal mucosa,2 5 8 9 and early oesophageal perforation2 5 8 9 with perioesophageal leakage, 2 5 (Fig. 1) communicating with a right lower lobe bronchus which filled only when the patient lay down and this reproduced his cough.
Despite supportive measures bronchopneumonia worsened, septicaemia developed, and he died nine weeks after sclerotherapy. Necropsy showed evidence of widespread bronchopneumonia with a 3 cm cavity in the right lower lobe contiguous with a 1.5 cm defect in the right lateral wall of the oesophagus just above the gastro-oesophageal junction (Fig. 2) .
It contained an open bronchus in Fig. 1 Bariumstudy demonstrating large cavity to the right its base. No varices were visible, there was 700 ml of ofthe lower oesophagus (fluid level) with narrowing ofthe ascitic fluid, the liver weighed 900 g and had the oesophagus immediately above it.
appearance of macronodular cirrhosis. Histopathology demonstrated obliterated submucosal oesophageal veins but patent peri-oesophageal viens. 
Discussion
The mechanism of delayed oesophageal necrosis in our patient after injection sclerotherapy was presumed to have been the result of inadvertant submucosal extravasation of sclerosant. This has been shown to produce coagulation necrosis in dogs15 and in man,3 10 13 although perivascular injection is recommended as a technique in some centres10 13 14 to induce submucosal fibrosis and obliteration of varices. Intravascularly injected sclerosant rapidly disperses in a cephalad direction if no compression technique is used3 10 16 and accidental perivascular leakage may occur. By adding radiographic contrast medium to the sclerosant solution and performing injection under fluoroscopy, we have found that the sclerosant solution remains within the varix injected while the varix is both positioned in the over-tube window and after rotation of the over-tube to achieve compression. The quantity of sclerosant we used in our patient was comparable with that used by others.1 2 8 9 12 14 It is, therefore, difficult to understand how extensive extravasation of sclerosant could have occurred in our patient. It is possible that the concomitant administration of corticosteroids played some part in minimising the local reaction around oesophageal necrosis and allowed the slow development of a peri-oesophageal cavity within the right lung and subsequent erosion into a bronchus. All currently reported experience with injection sclerotherapy shows it to be a highly effective method of arresting acute haemorrhage from oesophageal varices in about 90% of cases.1 2 6 7 9 13 Major complications of sclerotherapy have occurred in 2_44%1 7 9 13 of injection treatments, although many are primarily consequences of rigid oesophagoscopy such as oesophageal tears2 5 8 9 and leakage.' 2 5 Our case report represents the only major complication of our experience so far with 26 patients, giving an overall mean complication rate from the literature of about 12%. The number of recent reports would suggest that endoscopic sclerotherapy is becoming more popular as the preferred treatment for the management of patients with bleeding oesophageal varices, and the possibility of a major complication such as that described here should be considered in the event of new oesophageal or chest symptoms developing after 
